List of Tables
Table 1. Global Atropine Sulfate Eye Drop Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Atropine Sulfate Eye Drop Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Atropine Sulfate Eye Drop Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Atropine Sulfate Eye Drop Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Atropine Sulfate Eye Drop Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Atropine Sulfate Eye Drop Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Atropine Sulfate Eye Drop Sales by Region (2020-2025) & (K Units)
Table 8. Global Atropine Sulfate Eye Drop Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Atropine Sulfate Eye Drop Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Atropine Sulfate Eye Drop Sales Share by Manufacturers (2020-2025)
Table 12. Global Atropine Sulfate Eye Drop Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Atropine Sulfate Eye Drop Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Atropine Sulfate Eye Drop by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atropine Sulfate Eye Drop as of 2024)
Table 16. Global Atropine Sulfate Eye Drop Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Atropine Sulfate Eye Drop Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Atropine Sulfate Eye Drop Manufacturing Base and Headquarters
Table 19. Global Atropine Sulfate Eye Drop Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Atropine Sulfate Eye Drop Sales by Type (2020-2025) & (K Units)
Table 23. Global Atropine Sulfate Eye Drop Sales by Type (2026-2031) & (K Units)
Table 24. Global Atropine Sulfate Eye Drop Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Atropine Sulfate Eye Drop Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Atropine Sulfate Eye Drop ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Atropine Sulfate Eye Drop Sales by Application (2020-2025) & (K Units)
Table 29. Global Atropine Sulfate Eye Drop Sales by Application (2026-2031) & (K Units)
Table 30. Atropine Sulfate Eye Drop High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Atropine Sulfate Eye Drop Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Atropine Sulfate Eye Drop Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Atropine Sulfate Eye Drop ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Atropine Sulfate Eye Drop Growth Accelerators and Market Barriers
Table 37. North America Atropine Sulfate Eye Drop Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Atropine Sulfate Eye Drop Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Atropine Sulfate Eye Drop Growth Accelerators and Market Barriers
Table 40. Europe Atropine Sulfate Eye Drop Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Atropine Sulfate Eye Drop Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Atropine Sulfate Eye Drop Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Atropine Sulfate Eye Drop Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Atropine Sulfate Eye Drop Growth Accelerators and Market Barriers
Table 45. Southeast Asia Atropine Sulfate Eye Drop Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Atropine Sulfate Eye Drop Investment Opportunities and Key Challenges
Table 47. Central and South America Atropine Sulfate Eye Drop Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Atropine Sulfate Eye Drop Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Atropine Sulfate Eye Drop Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. GMT Pharma International Corporation Information
Table 51. GMT Pharma International Description and Major Businesses
Table 52. GMT Pharma International Product Models, Descriptions and Specifications
Table 53. GMT Pharma International Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. GMT Pharma International Sales Value Proportion by Product in 2024
Table 55. GMT Pharma International Sales Value Proportion by Application in 2024
Table 56. GMT Pharma International Sales Value Proportion by Geographic Area in 2024
Table 57. GMT Pharma International Atropine Sulfate Eye Drop SWOT Analysis
Table 58. GMT Pharma International Recent Developments
Table 59. AdvaCare Pharma Corporation Information
Table 60. AdvaCare Pharma Description and Major Businesses
Table 61. AdvaCare Pharma Product Models, Descriptions and Specifications
Table 62. AdvaCare Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. AdvaCare Pharma Sales Value Proportion by Product in 2024
Table 64. AdvaCare Pharma Sales Value Proportion by Application in 2024
Table 65. AdvaCare Pharma Sales Value Proportion by Geographic Area in 2024
Table 66. AdvaCare Pharma Atropine Sulfate Eye Drop SWOT Analysis
Table 67. AdvaCare Pharma Recent Developments
Table 68. Jacobson Pharma Corporation Limited Corporation Information
Table 69. Jacobson Pharma Corporation Limited Description and Major Businesses
Table 70. Jacobson Pharma Corporation Limited Product Models, Descriptions and Specifications
Table 71. Jacobson Pharma Corporation Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Jacobson Pharma Corporation Limited Sales Value Proportion by Product in 2024
Table 73. Jacobson Pharma Corporation Limited Sales Value Proportion by Application in 2024
Table 74. Jacobson Pharma Corporation Limited Sales Value Proportion by Geographic Area in 2024
Table 75. Jacobson Pharma Corporation Limited Atropine Sulfate Eye Drop SWOT Analysis
Table 76. Jacobson Pharma Corporation Limited Recent Developments
Table 77. Bausch & Lomb U.K Limited Corporation Information
Table 78. Bausch & Lomb U.K Limited Description and Major Businesses
Table 79. Bausch & Lomb U.K Limited Product Models, Descriptions and Specifications
Table 80. Bausch & Lomb U.K Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Bausch & Lomb U.K Limited Sales Value Proportion by Product in 2024
Table 82. Bausch & Lomb U.K Limited Sales Value Proportion by Application in 2024
Table 83. Bausch & Lomb U.K Limited Sales Value Proportion by Geographic Area in 2024
Table 84. Bausch & Lomb U.K Limited Atropine Sulfate Eye Drop SWOT Analysis
Table 85. Bausch & Lomb U.K Limited Recent Developments
Table 86. Sun Pharmaceuticals Corporation Information
Table 87. Sun Pharmaceuticals Description and Major Businesses
Table 88. Sun Pharmaceuticals Product Models, Descriptions and Specifications
Table 89. Sun Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Sun Pharmaceuticals Sales Value Proportion by Product in 2024
Table 91. Sun Pharmaceuticals Sales Value Proportion by Application in 2024
Table 92. Sun Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
Table 93. Sun Pharmaceuticals Atropine Sulfate Eye Drop SWOT Analysis
Table 94. Sun Pharmaceuticals Recent Developments
Table 95. Iskon Remedies Corporation Information
Table 96. Iskon Remedies Description and Major Businesses
Table 97. Iskon Remedies Product Models, Descriptions and Specifications
Table 98. Iskon Remedies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Iskon Remedies Recent Developments
Table 100. Martindale Pharma Corporation Information
Table 101. Martindale Pharma Description and Major Businesses
Table 102. Martindale Pharma Product Models, Descriptions and Specifications
Table 103. Martindale Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Martindale Pharma Recent Developments
Table 105. Aspire Pharma Ltd Corporation Information
Table 106. Aspire Pharma Ltd Description and Major Businesses
Table 107. Aspire Pharma Ltd Product Models, Descriptions and Specifications
Table 108. Aspire Pharma Ltd Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Aspire Pharma Ltd Recent Developments
Table 110. OSRX Corporation Information
Table 111. OSRX Description and Major Businesses
Table 112. OSRX Product Models, Descriptions and Specifications
Table 113. OSRX Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. OSRX Recent Developments
Table 115. Xingqi Ophthalmic Medicine Corporation Information
Table 116. Xingqi Ophthalmic Medicine Description and Major Businesses
Table 117. Xingqi Ophthalmic Medicine Product Models, Descriptions and Specifications
Table 118. Xingqi Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Xingqi Ophthalmic Medicine Recent Developments
Table 120. Key Raw Materials Distribution
Table 121. Raw Materials Key Suppliers
Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 123. Milestones in Production Technology Evolution
Table 124. Distributors List
Table 125. Market Trends and Market Evolution
Table 126. Market Drivers and Opportunities
Table 127. Market Challenges, Risks, and Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Atropine Sulfate Eye Drop Product Picture
Figure 2. Global Atropine Sulfate Eye Drop Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Concentration 0.01% Product Picture
Figure 4. Concentration 0.1% Product Picture
Figure 5. Concentration 0.5% Product Picture
Figure 6. Global Atropine Sulfate Eye Drop Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Others
Figure 10. Atropine Sulfate Eye Drop Report Years Considered
Figure 11. Global Atropine Sulfate Eye Drop Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Atropine Sulfate Eye Drop Revenue (2020-2031) & (US$ Million)
Figure 13. Global Atropine Sulfate Eye Drop Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Atropine Sulfate Eye Drop Revenue Market Share by Region (2020-2031)
Figure 15. Global Atropine Sulfate Eye Drop Sales (2020-2031) & (K Units)
Figure 16. Global Atropine Sulfate Eye Drop Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Atropine Sulfate Eye Drop Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Atropine Sulfate Eye Drop Sales Volume Market Share in 2024
Figure 19. Global Atropine Sulfate Eye Drop Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Concentration 0.01% Revenue Market Share by Manufacturer in 2024
Figure 22. Concentration 0.1% Revenue Market Share by Manufacturer in 2024
Figure 23. Concentration 0.5% Revenue Market Share by Manufacturer in 2024
Figure 24. Global Atropine Sulfate Eye Drop Sales Market Share by Type (2020-2031)
Figure 25. Global Atropine Sulfate Eye Drop Revenue Market Share by Type (2020-2031)
Figure 26. Global Atropine Sulfate Eye Drop Sales Market Share by Application (2020-2031)
Figure 27. Global Atropine Sulfate Eye Drop Revenue Market Share by Application (2020-2031)
Figure 28. North America Atropine Sulfate Eye Drop Sales YoY (2020-2031) & (K Units)
Figure 29. North America Atropine Sulfate Eye Drop Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Atropine Sulfate Eye Drop Sales Revenue (US$ Million) in 2024
Figure 31. North America Atropine Sulfate Eye Drop Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Atropine Sulfate Eye Drop Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Atropine Sulfate Eye Drop Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Atropine Sulfate Eye Drop Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Atropine Sulfate Eye Drop Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Atropine Sulfate Eye Drop Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Atropine Sulfate Eye Drop Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Atropine Sulfate Eye Drop Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Atropine Sulfate Eye Drop Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Atropine Sulfate Eye Drop Sales Revenue (US$ Million) in 2024
Figure 41. Europe Atropine Sulfate Eye Drop Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Atropine Sulfate Eye Drop Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Atropine Sulfate Eye Drop Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Atropine Sulfate Eye Drop Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Atropine Sulfate Eye Drop Revenue (2020-2031) & (US$ Million)
Figure 46. France Atropine Sulfate Eye Drop Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Atropine Sulfate Eye Drop Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Atropine Sulfate Eye Drop Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Atropine Sulfate Eye Drop Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Atropine Sulfate Eye Drop Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Atropine Sulfate Eye Drop Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Atropine Sulfate Eye Drop Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Atropine Sulfate Eye Drop Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Atropine Sulfate Eye Drop Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Atropine Sulfate Eye Drop Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Atropine Sulfate Eye Drop Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Atropine Sulfate Eye Drop Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Atropine Sulfate Eye Drop Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Atropine Sulfate Eye Drop Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Atropine Sulfate Eye Drop Revenue (2020-2031) & (US$ Million)
Figure 61. India Atropine Sulfate Eye Drop Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Atropine Sulfate Eye Drop Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Atropine Sulfate Eye Drop Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Atropine Sulfate Eye Drop Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Atropine Sulfate Eye Drop Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Atropine Sulfate Eye Drop Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Atropine Sulfate Eye Drop Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Atropine Sulfate Eye Drop Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Atropine Sulfate Eye Drop Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Atropine Sulfate Eye Drop Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Atropine Sulfate Eye Drop Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Atropine Sulfate Eye Drop Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Atropine Sulfate Eye Drop Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Atropine Sulfate Eye Drop Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Atropine Sulfate Eye Drop Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Atropine Sulfate Eye Drop Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Atropine Sulfate Eye Drop Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Atropine Sulfate Eye Drop Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Atropine Sulfate Eye Drop Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Atropine Sulfate Eye Drop Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Atropine Sulfate Eye Drop Revenue (2020-2025) & (US$ Million)
Figure 82. Atropine Sulfate Eye Drop Industry Chain Mapping
Figure 83. Regional Atropine Sulfate Eye Drop Manufacturing Base Distribution (%)
Figure 84. Global Atropine Sulfate Eye Drop Production Market Share by Region (2020-2031)
Figure 85. Atropine Sulfate Eye Drop Production Process
Figure 86. Regional Atropine Sulfate Eye Drop Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
